News Articles Tagged: Hedgehog Inhibitors

Cyclopamine in Pharmaceutical R&D: From Discovery to Development

Explore the journey of Cyclopamine (CAS 4449-51-8) in pharmaceutical R&D, from its role as a research tool to its potential as a therapeutic agent.

Navigating the Challenges: IPI-926 and the Evolving Landscape of Pancreatic Cancer Therapy

An examination of IPI-926's journey in clinical trials for pancreatic cancer, the complexities of targeting the Hedgehog pathway, and the continuous search for effective treatments.

Advancing Pancreatic Cancer Treatment: The Science Behind IPI-926 and Hedgehog Pathway Inhibition

Delve into the scientific rationale and clinical implications of using IPI-926 to inhibit the Hedgehog pathway in the treatment of pancreatic cancer.